‌

US Patent 11419854 Medicament containing pemafibrate

Patent 11419854 was granted and assigned to Kowa Company, Ltd. on August, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Kowa Company, Ltd.

Current Assignee

Kowa Company, Ltd.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

114198540

Patent Inventor Names

Satoshi Kojima0

Ryohei Tanigawa0

Date of Patent

August 23, 2022

Patent Application Number

166092490

Date Filed

June 29, 2018

Patent Citations Received

‌

US Patent 11554109 Pemafibrate dosing regimens

Patent Primary Examiner

CPC Code

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11419854 Medicament containing pemafibrate

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API